DUSSELDORF, Germany, Aug. 23, 2019 /PRNewswire/ -- LenioBio GmbH today announced that the company has been awarded a grant of €2.37 million to accelerate the scale-up of its proprietary protein expression platform ALiCE®. Today's drug development process is cumbersome and expensive. On...